Seodong Medical's 'Nuri Eye 5800' won the 2022 Korea 4th Industry Leading Company Grand Prize

Seodong Medical (CEO Kim Chang-on) won the grand prize in the product innovation category at the Money Today ‘1 Korea 2022th Industry Leading Company Awards’ awards ceremony held at the Korea Press Center in Jung-gu, Seoul on the 4st.

The 'Korea 4th Industry Leading Company Award' was established to recognize and encourage outstanding companies that fulfill their social responsibilities through differentiated technology, management, and products in line with the digital transformation trend of the 4th Industrial Revolution.

Seodong Medical has been focusing on developing treatment solutions related to eye diseases since its establishment in 1996. As a result, the 'NURIEYE 2008' model developed in 5800 is the only dry eye treatment medical device approved for safety and effectiveness through clinical data review.

Previously, dry eye patients visited an ophthalmologist whenever they had symptoms, received prescriptions for eye drops and simple eye physical therapy, and repeated makeshift treatments. NURIEYE 5800 is a medical device that helps treat and prevent dry eye syndrome and reduce intraocular pressure. Clinical trials were conducted on 144 people at Pusan ​​National University Hospital and Inje University Busan Paik Hospital. In addition, it has been officially approved by the Ministry of Food and Drug Safety and is recognized as non-reimbursable by insurance (MZ013), so it is used for treatment in eye hospitals.

Nuri Eye 5800 gently relaxes the skin muscles around the eyes with vibration massage and pneumatic massage, helping to improve circulation of nerves, blood vessels, and tears. In addition, a warm thermal massage melts foreign substances stuck or accumulated in the eye and hardened fatty secretions from the meibomian glands inside the eyelids, helping tear circulation.

Seodong Medical said, “Dry eye syndrome is a serious disease that not only causes great pain and difficulty due to the disease itself, but if left untreated, it can lead to cataracts, glaucoma, vision loss, visual field damage, depression, and lethargy.” “Even though the eyes are the most precious in the human body, “It is no exaggeration to say that we must use products that have been proven safe and effective,” he emphasized. He added, “Many people ignore presbyopia, recognizing it as an inevitable aging process, but it is important to maintain healthy eyes through consistent care.”

Seodong Medical is recognized for its technology and safety by publishing SCI papers in the renowned British Journal of Ophthalmology (BJO), as well as obtaining various patents (eye massager, eye massage, facial massage, etc.) and overseas certification (US FDA).

Seodong Medical officials said, “We will continue to focus on technology development and research activities to become a top-tier company that can lead the way in treating eye-related diseases not only in Korea but also in people around the world.”